Legal Representation
Attorney
Mark Lerner, Esq.
USPTO Deadlines
Next Deadline
1326 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-02-28)
Due Date
February 28, 2029
Grace Period Ends
August 28, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
22 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 2, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Feb 28, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Feb 28, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jan 25, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Jan 24, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Jan 24, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Jan 23, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Dec 20, 2022 | IUAF | S | USE AMENDMENT FILED |
| Dec 20, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Oct 25, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Aug 30, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Aug 30, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 10, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jul 25, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 14, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jul 14, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jul 14, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Jul 14, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jul 7, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 30, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Oct 29, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 7, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances, namely, topical preparations for the relief of aches, pain, discomfort and muscle soreness; analgesic balm; topical analgesics
First Use Anywhere:
20220200
First Use in Commerce:
20220200
Additional Information
Design Mark
The mark consists of the words "CLINICALLY RECOMMENDED" followed by the asterisk symbol all within a circle, with a check mark design at its center.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CLINICALLY RECOMMENDED"
USPTO Documents
Loading USPTO documents...